ReviewPolymers2025
Green Processes for Chitin and Chitosan Production from Insects: Current State, Challenges, and Opportunities.
Review in Polymers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Article
- Article
- Fungal and Microalgal Chitin: Structural Differences, Functional Properties, and Biomedical Applications.Polymers · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Chitin and chitosan are valuable biopolymers with various applications, ranging from food to pharmaceuticals. Traditionally sourced from crustaceans, the rising demand for chitin/chitosan, paired with the development of the insect sector, has led to the exploration of insect biomass and its byproducts as a potential source. Conventional processes rely on hazardous chemicals, raising environmental concerns. This critical review evaluates emerging "greener" approaches, including biological methods, green solvents, and advanced processing techniques, for chitin/chitosan production from insect-derived materials such as exuviae and cocoons. Two systematic evaluations are included: (1) a cross-comparison of chitin and chitosan yields across insect life stages and byproducts (e.g., up to 35.7% chitin from black soldier fly (BSF) larval exoskeletons can be obtained) and (2) a stepwise sustainability assessment of over 30 extraction workflows reported across 16 studies. While many are labeled as green, only a few, such as bromelain, lactic acid fermentations, or NADES-based processes, demonstrated fully green extraction up to the chitin stage. No study achieved a fully green conversion to chitosan, and green workflows typically required materials with low fat content and minimal pretreatment. These findings will be useful to identify opportunities and underscore the need to refine greener methods, improve yields, reduce impurities, and enable industrial-scale production, while sustainability data need to be generated.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.